Account

Table 7 Review of the literature regarding c-erbB2/HER2 concordance

From: Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature

	No of samples	Concordance (%)	IHC
Burge, 2006 [26]	81	96	Dako
Wood, 2007 [28]	100	86.6	Dako
Arnedos, 2009 [29]	331	98.8	Ventana
Lebeau, 2010 [51]	500	90,4	Dako
Tamaki, 2010 [30]	353	89.3	Ventana
Lorgis, 2011* [32]	175	98.3	Ventana
Ough, 2011 [33]	209	56	Not reported
Lee, 2012* [52]	300	98	Dako
Seferina, 2012° [35]	526	80.6	Dako
Dekker, 2013 [36]	122	96.4	Dako
Munch-Petersen, 2013 [38]	89	84.0	Ventana
Motamedolshariati, 2014 [39]	30	93.3	Dako
Chen, 2017 [40]	941	62.6	Ventana
Ensani, 2017 [41]	100	97.3	Not reported
Kombak, 2017 [42]	243	90.1	Leica
You, 2017 [44]	1219	84.6	Ventana
Slostad, 2022 [48]	961	73.4%	LDT

*IHC + FISH, °IHC + SISH (Ventana), IHC immunohistochemistry, LDT laboratory-developed test

Back to article page